icovamenib 100mg for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2026: Trial started, NCT07502495
  2. 31 Mar 2026: Trial registered, NCT07502495

The trials

NCT07502495: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

State
Under way
Phase
Phase 2
People
64 taking part
Started
27 Mar 2026
Primary completion
Mar 2027
Arms
Arm A: icovamenib 100 mg
Results
None posted
  1. 27 Mar 2026: Trial started
  2. 31 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.